CRP and interstitial lung disease: Plasma Hsp90 demonstrated slightly superior ability to discriminate IIM patients from healthy controls, as well as IIM patients with interstitial lung disease or cardiac involvement from those without these manifestations, when compared to traditional soluble biomarkers such as CRP and CK.